CRVO
CervoMed Inc.
2.50$
-0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.2% | -19.8% | +565.1% | -8.1% | -11.9% | -10.5% | -1.3% | -19.6% | -23.6% | -35.4% | +72.0% | |
| – | -15.9% | -20.1% | +494.2% | +3.1% | -11.7% | -10.5% | -1.3% | -19.6% | -26.3% | -33.0% | +72.0% | |
| – | -25.2% | -18.3% | +57.2% | -22.6% | +16.2% | +16.7% | -20.8% | +13.4% | -12.7% | -3.6% | +182.8% | |
| – | -25.2% | -18.3% | +608.0% | +3.5% | -16.6% | -9.4% | -4.9% | -18.6% | -23.6% | -38.1% | +93.0% | |
| – | – | – | – | – | +753.4% | -27.7% | +44.9% | -42.3% | -68.6% | – | – | |
| – | +5.4% | +2.5% | +20.8% | +1.0% | +19.5% | +1.6% | +17.7% | -0.9% | +12.6% | -13.1% | -32.6% | |
| – | +5.4% | +2.5% | +20.8% | +1.0% | +19.5% | +1.6% | -53.2% | +149.2% | +1.2% | -3.4% | -32.6% | |
| – | +24.1% | +2.6% | +6.8% | +49.1% | +39.6% | +23.1% | -0.8% | -26.9% | +7.8% | +56.3% | -69.8% | |
| – | -23.0% | -27.7% | +836.5% | -8.7% | -14.1% | -11.7% | -3.4% | -22.2% | -29.9% | -41.7% | +116.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.7% | +8.7% | +41.0% | +0.0% | +0.0% | +0.0% | +2.8% | +3.4% | +0.0% | +0.1% | +10.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.